Direct Combination Evidence Matrix
Whether each stack on the site has direct combination evidence, or is inferred from single-compound studies.
Educational research-literacy content only. Not medical advice, not dosing guidance, not sourcing advice, and not a protocol for human or animal use. See our responsible information policy.
Most combinations on this site have no direct combination evidence — their rationale is inferred from monotherapy literature on the individual peptides. For BPC-157 + TB-500, PubMed, 6 November 2026, ("BPC-157"[tiab] OR "BPC 157"[tiab] OR "BPC157"[tiab]) AND ("TB-500"[tiab] OR "TB500"[tiab] OR "TB 500"[tiab]): 12 records, 0 with publication type Clinical Trial. They include one controlled study (32 rats, Achilles tendon repair) that reported the combination “did not confer additional benefits compared to either agent alone” (Biçer 2026, PMID 42542926), and a three-patient uncontrolled case report in which both were given with other peptides and drugs (Froum 2026, PMID 42876687). A 2021 knee-pain chart review included 4 patients given BPC-157 with thymosin beta-4, called TB4 in its abstract and not TB-500 (Lee 2021, PMID 34324435). For CJC-1295 with ipamorelin, PubMed on 6 November 2026 for CJC-1295 AND ipamorelin returned 11 records, and 0 when AND Clinical Trial[pt] was added. A 2026 review notes a murine finding for the combination that it says is “limited to animal studies” (Mayfield 2026, PMID 41476424). See: direct vs inferred stacks and why synergy is often assumed, not demonstrated.
| Stack | Direct combo evidence | Human data | Grade | Main uncertainty |
|---|---|---|---|---|
| BPC-157 + TB-500 — Research Evidence Review: Tissue-Repair Mechanisms & Translational Limits | limited | indirect | C | The combination has been compared with its components in only one study, in rats (PMID 42542926), which found no added benefit from combining them. |
| TB-500 + BPC-157 — Research Evidence Review: Tendon Repair Mechanisms & Study Models | limited | indirect | C | The combination has been compared with its components in only one study, in rats (PMID 42542926), which found no added benefit from combining them. |
| BPC-157 + GHK-Cu — Research Evidence Review: Follicular Mechanisms & Evidence Limits | no | indirect | C | Evidence for the combination is separate from evidence for each compound alone; the mechanism is largely inferred from single-compound studies. |
| BPC-157 + KPV + Thymosin α-1 — Research Evidence Review: Immune & Mucosal Mechanisms | no | indirect | C | Evidence for the combination is separate from evidence for each compound alone; the mechanism is largely inferred from single-compound studies. |
| BPC-157 + TB-500 + GHK-Cu — Research Evidence Review: Tissue-Repair & Remodelling Mechanisms | no | indirect | C | Evidence for the combination is separate from evidence for each compound alone; the mechanism is largely inferred from single-compound studies. |
| CJC-1295 + Ipamorelin + Tesamorelin — Research Evidence Review: GH Axis Mechanisms & Study Limitations | no | indirect | C | Evidence for the combination is separate from evidence for each compound alone; the mechanism is largely inferred from single-compound studies. |
| Cerebrolysin + Semax — Research Evidence Review: Neuropeptide & BDNF-Axis Mechanisms | no | indirect | C | Evidence for the combination is separate from evidence for each compound alone; the mechanism is largely inferred from single-compound studies. |
| DSIP + Selank — Research Evidence Review: What Has Been Studied in People | no | indirect | C | Evidence for the combination is separate from evidence for each compound alone; the mechanism is largely inferred from single-compound studies. |
| Epitalon + Humanin + MOTS-c — Research Evidence Review: What Has Been Studied | no | indirect | C | Evidence for the combination is separate from evidence for each compound alone; the mechanism is largely inferred from single-compound studies. |
| Epithalon + Thymalin — Research Evidence Review: Khavinson Bioregulator Mechanisms | no | indirect | C | Evidence for the combination is separate from evidence for each compound alone; the mechanism is largely inferred from single-compound studies. |
| GHK-Cu + TB-500 — Research Evidence Review: Dermal Remodelling Mechanisms | no | indirect | C | Evidence for the combination is separate from evidence for each compound alone; the mechanism is largely inferred from single-compound studies. |
| Ipamorelin + CJC-1295 + BPC-157 — Research Evidence Review: GH Axis + Tissue-Repair Mechanisms | no | indirect | C | Evidence for the combination is separate from evidence for each compound alone; the mechanism is largely inferred from single-compound studies. |
| KPV + LL-37 — Research Evidence Review: Mucosal & Antimicrobial Mechanisms | no | indirect | C | Evidence for the combination is separate from evidence for each compound alone; the mechanism is largely inferred from single-compound studies. |
| MOTS-c + AOD-9604 — Research Evidence Review: Mitochondrial & Lipolytic Mechanisms | no | no | D | Evidence for the combination is separate from evidence for each compound alone; the mechanism is largely inferred from single-compound studies. |
| Melanotan II + Bremelanotide — Research Evidence Review: Melanocortin Mechanisms & Safety Signals | no | indirect | C | Evidence for the combination is separate from evidence for each compound alone; the mechanism is largely inferred from single-compound studies. |
| PT-141 + Kisspeptin-10 — Research Evidence Review: Melanocortin & Reproductive-Axis Mechanisms | no | indirect | C | Evidence for the combination is separate from evidence for each compound alone; the mechanism is largely inferred from single-compound studies. |
| SS-31 + Humanin — Research Evidence Review: Mitochondrial Mechanisms | no | indirect | C | Evidence for the combination is separate from evidence for each compound alone; the mechanism is largely inferred from single-compound studies. |
| SS-31 + MOTS-c — Research Evidence Review: Mitochondrial Cardiovascular Mechanisms | no | indirect | C | Evidence for the combination is separate from evidence for each compound alone; the mechanism is largely inferred from single-compound studies. |
| Semax + Selank + Pinealon — Research Evidence Review: Neuropeptide Mechanisms & Translational Limits | no | indirect | C | Evidence for the combination is separate from evidence for each compound alone; the mechanism is largely inferred from single-compound studies. |
| Tesamorelin + AOD-9604 — Research Evidence Review: Visceral Adipose Research Context | no | indirect | C | Evidence for the combination is separate from evidence for each compound alone; the mechanism is largely inferred from single-compound studies. |
| Tirzepatide + Retatrutide + AOD-9604 — Research Evidence Review: Incretin & Lipolytic Mechanisms | no | indirect | C | Evidence for the combination is separate from evidence for each compound alone; the mechanism is largely inferred from single-compound studies. |
| CagriSema (Semaglutide + Cagrilintide) — Evidence Review | yes | yes | B | Combination evidence exists but should be read alongside study-quality and replication caveats. |
If you spot an error or have new evidence to suggest, please use our corrections policy.